Evidence map›Paper›PMID 40790882›Full record

ArticleDrug delivery2025

Enhanced

Zelin Zheng, Zijie Li, Mingqi Yu, Xinyi Ma, Jie Gao, Yan Wang, Jinyan Wu, Xiaodan Yu, Yinzheng Ma, Xiaowen He

Abstract read
In one paragraph

Article in Drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in pharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zelin ZhengSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Zijie LiSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Mingqi YuSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Xinyi MaSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Jie GaoSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Yan WangResearch Institute for Science and Technology Development, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Jinyan WuResearch Institute for Science and Technology Development, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Xiaodan YuResearch Institute for Science and Technology Development, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Yinzheng MaSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.
Xiaowen HeSchool of Pharmacy, Hainan Medical University (Hainan Academy of Medical Sciences), Haikou, China.ORCID 0000-0001-7884-6047

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsCandida albicansCandidiasisCaricaDrug CarriersIsothiocyanatesLipidsNanostructuresAnimalsDrug Resistance, FungalFemaleFluconazoleMiceMice, Inbred BALB CMicrobial Sensitivity TestsParticle SizeAntifungal Agentsbenzyl isothiocyanateDrug CarriersFluconazoleIsothiocyanatesLipidsbenzyl isothiocyanateCandida albicansnanostructured lipid carrierPapaya seedsresistancesystemic candidiasis

Identifiers

PMID40790882
PMCPMC12344672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.